TUCSON   520.748.4400

Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO

3.6.2024

Complete Genomics and seqWell Announce Codevelopment Partnership

2.9.2024

TD2 Expands Preclinical and Clinical Services by Acquiring Flow Contract Site Laboratory (FCSL)

2.1.2024

AustinPx Partners with Microsize on KinetiSol® Technology

2.1.2024

S2 Genomics Raises Series A Round Led by RCT and BroadOak

1.24.2024

Pheon Therapeutics Appoints Cyrus Mozayeni, MD as CEO

7.25.2023

Introducing Motive: FDA-Cleared Knee Pain Relief Therapy

7.10.2023

Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals

7.5.2023

C-Path’s TRxA Accelerates its First Drug Development Projects with Support from RCT’s Cottrell Foundation

6.28.2023

BioTools Innovator Announces 2023 Cohort

6.6.2023